Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SOAFEE, Inc. (SOFE)
Atlanta, GA, US
SOAFEE, Inc. provides artificial intelligence (AI) and information technology (IT) services, and enterprise AI software-as a-service (SaaS) solutions for enterprises. It offers AI driven data as a service system (DaaS); SOAFEE healthcare marketplace; applied AI IT services for the health care/life sciences sector; and applied AI SaaS solutions for optimizing business operations. The company was formerly known as Carepay, Inc. and changed its name to SOAFEE, Inc. in February 2022. SOAFEE, Inc. is based in Atlanta, Georgia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +6.67% | +23.08% | +45.45% | +700.00% | -99.75% | -90.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+372.2% ★ Q4'22: +1,383.1% (vs Q1'12)
-
EPS growth Medical - Healthcare Information Services: +43.1%+2,120.0% ★ Q4'22: +106.9% (vs Q1'12)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+2.1% Q4'22: +28.8% (vs Q1'12)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+27.1% ★ Q4'22: +27.1% (vs Q1'12)
-
ROIC Medical - Healthcare Information Services: +5.2%+91.8% ★ Q4'22: +367.4% (vs Q1'12)
-
Share dilution Medical - Healthcare Information Services: -0.1%+0.0% ★ Q4'22: +745.5% (vs Q1'12)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-74.66× Q4'22: -29.43× (vs Q1'12)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2006 | Sonny Wooley Chairman | 156.0K | — | 20.0K | — | — | — | 176.0K | 11.36% | ↗ |
| 2 | 2006 | Timothy G. Byrd, Sr., CEO | 156.0K | — | 15.0K | — | — | — | 171.0K | 8.77% | ↗ |
| 3 | 2005 | Timothy G. Byrd, Sr., CEO | 96.0K | — | — | — | — | — | 96.0K | 0.00% | ↗ |
| 4 | 2005 | Sonny Wooley Chairman | 96.0K | — | — | — | — | — | 96.0K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hima Arimanda | Founder & Director | — | male |
| J. Eric Anderson | Chief Executive Officer | — | male |
| Julie Westcott | Vice President of Marketing | — | — |
| Russ Westcott | Chief Operating Officer | — | — |
| Seetha R. R. Muthavarapu | Chief Medical Director & Member of Advisory Board | — | — |
| Swaroop Kallakuri | Chief Technical Officer | — | — |
| Venkateswarlu Garikapati | Founder, President, Treasurer, Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SOFE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
